Infinity Pharmaceuticals | INFI - Equity Capital And Reserves


Infinity Pharmaceuticals reported $-37.41M in Equity Capital and Reserves for its fiscal quarter ending in June of 2023.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 21.41B 861M Jun/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Incyte USD 5.17B 516.28M Dec/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
J&J USD 78.47B 0 Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Plus Therapeutics USD -1.35M 3.97M Dec/2023
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025